Mobile

An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin

Update Il y a 4 ans
Reference: NCT00274443

Woman and Man

Extract

This is an open-label dose escalation trial using ABI-007 plus carboplatin.

Inclusion criteria

  • Non small cell lung cancer (NSCLC)

Links